Literature DB >> 17644219

Differential role of kinin B1 and B2 receptors in ischemia-induced apoptosis and ventricular remodeling.

Hang Yin1, Julie Chao, Michael Bader, Lee Chao.   

Abstract

We investigated the role of kinin receptors in cardiac remodeling after ischemia/reperfusion (I/R). Bradykinin injection improved cardiac contractility, diastolic function, reduced infarct size and prevented left ventricular thinning after I/R, whereas des-Arg(9)-BK injection had no protective effects. Bradykinin, but not des-Arg(9)-BK, reduced cardiomyocyte apoptosis and increased Akt and GSK-3beta phosphorylation. Furthermore, myocardial infarct size was similar between wild type and B2 knockout mice after I/R, but significantly reduced in kinin B1 receptor knockout mice. These results indicate that the kinin B2 receptor, but not the B1 receptor, protects against I/R-induced cardiac dysfunction by inhibiting apoptosis and limiting ventricular remodeling.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17644219      PMCID: PMC2067250          DOI: 10.1016/j.peptides.2007.05.010

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  23 in total

1.  Role of bradykinin B2 and B1 receptors in the local, remote, and systemic inflammatory responses that follow intestinal ischemia and reperfusion injury.

Authors:  Danielle G Souza; Eliane S L Lomez; Vanessa Pinho; João Bosco Pesquero; Michael Bader; Jorge Luís Pesquero; Mauro M Teixeira
Journal:  J Immunol       Date:  2004-02-15       Impact factor: 5.422

2.  Bradykinin B2 receptor is involved in the late phase of preconditioning in rabbit heart.

Authors:  C Kositprapa; R A Ockaili; R C Kukreja
Journal:  J Mol Cell Cardiol       Date:  2001-07       Impact factor: 5.000

3.  Bradykinin mediates cardiac preconditioning at a distance.

Authors:  R G Schoemaker; C L van Heijningen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-05       Impact factor: 4.733

4.  Kallidin-like peptide mediates the cardioprotective effect of the ACE inhibitor captopril against ischaemic reperfusion injury of rat heart.

Authors:  Xiuxin Liu; Martina Lukasova; Radka Zubakova; Sabina Lewicka; Ulrich Hilgenfeldt
Journal:  Br J Pharmacol       Date:  2006-06-12       Impact factor: 8.739

5.  Bradykinin limits infarction when administered as an adjunct to reperfusion in mouse heart: the role of PI3K, Akt and eNOS.

Authors:  Robert M Bell; Derek M Yellon
Journal:  J Mol Cell Cardiol       Date:  2003-02       Impact factor: 5.000

6.  Detrimental implication of B1 receptors in myocardial ischemia: evidence from pharmacological blockade and gene knockout mice.

Authors:  Caroline Lagneux; Michael Bader; João B Pesquero; Pierre Demenge; Christophe Ribuot
Journal:  Int Immunopharmacol       Date:  2002-05       Impact factor: 4.932

7.  Bradykinin B1 and B2 receptors differentially regulate cardiac Na+-H+ exchanger, Na+-Ca2+ exchanger and Na+-HCO3- symporter.

Authors:  Steffen Sandmann; Elena Kaschina; Annegret Blume; Marie Luise Kruse; Thomas Unger
Journal:  Eur J Pharmacol       Date:  2003-01-01       Impact factor: 4.432

8.  The bradykinin B1 receptor contributes to the cardioprotective effects of AT1 blockade after experimental myocardial infarction.

Authors:  Carsten Tschöpe; Frank Spillmann; Christine Altmann; Matthias Koch; Dirk Westermann; Nasser Dhayat; Sameer Dhayat; Jean-Loup Bascands; Lajos Gera; Sigrid Hoffmann; Heinz-Peter Schultheiss; Thomas Walther
Journal:  Cardiovasc Res       Date:  2004-02-15       Impact factor: 10.787

9.  Bradykinin inhibits development of myocardial infarction through B2 receptor signalling by increment of regional blood flow around the ischaemic lesions in rats.

Authors:  Hiroshi Ito; Izumi Hayashi; Tohru Izumi; Masataka Majima
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

10.  Bradykinin induces mitochondrial ROS generation via NO, cGMP, PKG, and mitoKATP channel opening and leads to cardioprotection.

Authors:  Olaf Oldenburg; Qining Qin; Thomas Krieg; Xi-Ming Yang; Sebastian Philipp; Stuart D Critz; Michael V Cohen; James M Downey
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-09-04       Impact factor: 4.733

View more
  16 in total

1.  Loss of bradykinin signaling does not accelerate the development of cardiac dysfunction in type 1 diabetic akita mice.

Authors:  Adam R Wende; Jamie Soto; Curtis D Olsen; Karla M P Pires; John C Schell; Frederic Larrieu-Lahargue; Sheldon E Litwin; Masao Kakoki; Nobuyuki Takahashi; Oliver Smithies; E Dale Abel
Journal:  Endocrinology       Date:  2010-05-25       Impact factor: 4.736

2.  Platelet-Membrane-Encapsulated Carvedilol with Improved Targeting Ability for Relieving Myocardial Ischemia-Reperfusion Injury.

Authors:  Tingting Zhou; Xuechao Yang; Tianyi Wang; Mingming Xu; Zhanghao Huang; Runze Yu; Yi Jiang; Youlang Zhou; Jiahai Shi
Journal:  Membranes (Basel)       Date:  2022-06-10

3.  Protective role of AT(2) and B(1) receptors in kinin B(2)-receptor-knockout mice with myocardial infarction.

Authors:  Jiang Xu; Oscar A Carretero; Liping Zhu; Edward G Shesely; Nour-Eddine Rhaleb; Xiangguo Dai; Luchen Wang; James J Yang; Xiao-Ping Yang
Journal:  Clin Sci (Lond)       Date:  2013-01       Impact factor: 6.124

4.  Loss of myocardial ischemic postconditioning in adenosine A1 and bradykinin B2 receptors gene knockout mice.

Authors:  Lei Xi; Anindita Das; Zhi-Qing Zhao; Vanessa F Merino; Michael Bader; Rakesh C Kukreja
Journal:  Circulation       Date:  2008-09-30       Impact factor: 29.690

5.  Novel bradykinin signaling in adult rat cardiac myocytes through activation of p21-activated kinase.

Authors:  Yunbo Ke; Katherine A Sheehan; E Eroume A Egom; Ming Lei; R John Solaro
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-02-12       Impact factor: 4.733

Review 6.  JAK redux: a second look at the regulation and role of JAKs in the heart.

Authors:  Mazen Kurdi; George W Booz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-08-28       Impact factor: 4.733

7.  Tissue kallikrein elicits cardioprotection by direct kinin b2 receptor activation independent of kinin formation.

Authors:  Julie Chao; Hang Yin; Lin Gao; Makoto Hagiwara; Bo Shen; Zhi-Rong Yang; Lee Chao
Journal:  Hypertension       Date:  2008-09-02       Impact factor: 10.190

8.  Effects of a novel bradykinin B1 receptor antagonist and angiotensin II receptor blockade on experimental myocardial infarction in rats.

Authors:  Dongmei Wu; Xinchun Lin; Christian Bernloehr; Tobias Hildebrandt; Henri Doods
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

9.  Angiotensin I-converting enzyme type 2 (ACE2) gene therapy improves glycemic control in diabetic mice.

Authors:  Sharell M Bindom; Chetan P Hans; Huijing Xia; A Hamid Boulares; Eric Lazartigues
Journal:  Diabetes       Date:  2010-07-26       Impact factor: 9.461

10.  Gene deletion of the kinin receptor B1 attenuates cardiac inflammation and fibrosis during the development of experimental diabetic cardiomyopathy.

Authors:  Dirk Westermann; Thomas Walther; Konstantinos Savvatis; Felcicitas Escher; Meike Sobirey; Alexander Riad; Michael Bader; Heinz-Peter Schultheiss; Carsten Tschöpe
Journal:  Diabetes       Date:  2009-03-10       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.